The Effects of Eszopiclone Treatment (3mg for Two Months) to Counteract the Adverse Metabolic Consequences of Primary Insomnia.
Phase of Trial: Phase II
Latest Information Update: 15 Nov 2013
At a glance
- Drugs Eszopiclone (Primary)
- Indications Insomnia
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 19 Nov 2007 New trial record.